GT Biopharma, Inc. (GTBP)

CIK 109657 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for GT Biopharma, Inc..

Recent SEC filings

FiledFormAccession number
Sep 3, 20268-K0001493152-26-041333
Aug 14, 20268-K0001493152-26-038446
Aug 14, 202610-Q0001493152-26-037988
Jul 2, 2026DEF 14A0001493152-26-031922
Jun 18, 2026PRE 14A0001493152-26-029362
Jun 12, 20268-K0001493152-26-028457
May 22, 20268-K0001493152-26-024913
May 15, 202610-Q0001493152-26-023346
May 13, 2026424B30001493152-26-022795
May 13, 2026EFFECT9999999995-26-001620
Apr 30, 2026S-10001493152-26-020697
Apr 7, 20268-K0001493152-26-015413
Mar 6, 202610-Q/A0001493152-26-009126
Mar 6, 202610-Q/A0001493152-26-009127
Mar 2, 202610-K0001493152-26-008443
Mar 2, 20268-K0001493152-26-008442
Jan 30, 2026424B30001493152-26-004547
Jan 30, 2026EFFECT9999999995-26-000420
Jan 21, 2026S-10001493152-26-003089
Jan 8, 2026424B30001493152-26-000976
Dec 2, 2025424B30001493152-25-025796
Dec 2, 2025EFFECT9999999995-25-003476
Nov 26, 20258-K0001493152-25-025162
Nov 14, 20258-K0001493152-25-022631
Nov 14, 202510-Q0001493152-25-023400